Literature DB >> 21794943

HIV testing in Europe: mapping policies.

Jessika Deblonde1, Herman Meulemans, Steven Callens, Stanley Luchters, Marleen Temmerman, Françoise F Hamers.   

Abstract

OBJECTIVES: In the absence of treatment and in the context of discrimination, HIV testing was embedded within exceptional procedures. With increasing treatment effectiveness, early HIV diagnosis became important, calling for the normalization of testing. National HIV testing policies were mapped to explore the characteristics and variations across European countries.
METHODS: Key informants within the health authorities of all EU/EEA countries were questioned on HIV testing policies, which were assessed within a conceptual framework and the level of exceptionalism and normalization was scored based on defined attributes.
RESULTS: Twenty-four out of 31 countries participated in the survey. Policies tended to support confidential voluntary testing, informed consent, and counselling. In the majority of countries, specific groups were targeted for provider-initiated testing. Taking together all attributes of HIV testing, 14 countries obtained a high score for exceptionalism, while only 3 achieved a high score on normalization. Italy, Lithuania and Romania had primarily exceptional procedures; Norway leant more towards normalization; Netherlands, the United Kingdom, and Denmark scored high in both.
CONCLUSIONS: In most EU/EEA countries, policies are integrating HIV testing in health care settings, through voluntary and targeted testing strategies. Current HIV testing policies exhibited a high level of exceptionalism with varying degrees of normalization. Further research should compare HIV testing policies with practices. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Mesh:

Year:  2011        PMID: 21794943     DOI: 10.1016/j.healthpol.2011.06.012

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  8 in total

1.  Self-reported historic human immunodeficiency virus (HIV) testing in a Brazilian blood donor HIV case-control study.

Authors:  Roberta Bruhn; Elizabeth Moreno; Ester C Sabino; Naura Aparecida F Ferreira; Anna Barbara F Carneiro-Proietti; Maria Esther D Lopes; Divaldo Sampaio; Paula Loureiro; Brian Custer; Thelma T Goncalez
Journal:  Transfusion       Date:  2016-09-09       Impact factor: 3.157

2.  Has testing been normalized? An analysis of changes in barriers to HIV testing among men who have sex with men between 2000 and 2010 in Scotland, UK.

Authors:  P Flowers; C Knussen; J Li; L McDaid
Journal:  HIV Med       Date:  2012-08-30       Impact factor: 3.180

3.  Provider-Initiated HIV Testing for Migrants in Spain: A Qualitative Study with Health Care Workers and Foreign-Born Sexual Minorities.

Authors:  Barbara Navaza; Bruno Abarca; Federico Bisoffi; Robert Pool; Maria Roura
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

4.  Patient choice in opt-in, active choice, and opt-out HIV screening: randomized clinical trial.

Authors:  Juan Carlos C Montoy; William H Dow; Beth C Kaplan
Journal:  BMJ       Date:  2016-01-19

5.  First HIV prevalence estimates of a representative sample of adult sub-Saharan African migrants in a European city. Results of a community-based, cross-sectional study in Antwerp, Belgium.

Authors:  Jasna Loos; Christiana Nöstlinger; Bea Vuylsteke; Jessika Deblonde; Morgan Ndungu; Ilse Kint; Lazare Manirankunda; Thijs Reyniers; Dorothy Adobea; Marie Laga; Robert Colebunders
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

6.  HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA): evidence from a systematic review.

Authors:  S Desai; L Tavoschi; A K Sullivan; L Combs; D Raben; V Delpech; S F Jakobsen; A J Amato-Gauci; S Croxford
Journal:  HIV Med       Date:  2019-11-14       Impact factor: 3.180

7.  Restricted access to antiretroviral treatment for undocumented migrants: a bottle neck to control the HIV epidemic in the EU/EEA.

Authors:  Jessika Deblonde; André Sasse; Julia Del Amo; Fiona Burns; Valerie Delpech; Susan Cowan; Michele Levoy; Lilana Keith; Anastasia Pharris; Andrew Amato-Gauci; Teymur Noori
Journal:  BMC Public Health       Date:  2015-12-10       Impact factor: 3.295

8.  Identifying key elements to inform HIV-testing interventions for primary care in Belgium.

Authors:  Hanne Apers; Christiana Nöstlinger; Dominique Van Beckhoven; Jessika Deblonde; Ludwig Apers; Katleen Verheyen; Jasna Loos
Journal:  Health Promot Int       Date:  2020-04-01       Impact factor: 2.483

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.